Related Experiment Video

Updated: Jun 13, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

Fungal infections in transplant and oncology patients

Anna K Person1, Dimitrios P Kontoyiannis, Barbara D Alexander

  • 1Division of Infectious Diseases, Department of Medicine, Duke University Health System, Duke University School of Medicine, Box 102359, Durham, NC 27710, USA. perso006@mc.duke.edu

Infectious Disease Clinics of North America
|May 15, 2010
PubMed

Insights

Recent advances in treating invasive fungal infections (IFIs) in transplant and oncology patients address new challenges and controversies. Ongoing research explores genetic factors and immunomodulation to improve patient outcomes.

Area of Science:

  • Infectious Diseases
  • Transplantation Medicine
  • Oncology

Background:

  • Epidemiology of invasive fungal infections (IFIs) is shifting in transplant and oncology populations.
  • New controversies and treatment recommendations have emerged.
  • Diagnosis and management of IFIs in these vulnerable groups remain challenging.

Purpose of the Study:

  • To highlight recent advances in the management of IFIs.
  • To discuss important factors in treating IFIs in transplant and oncology patients.
  • To address emerging challenges and controversies in IFI treatment.

Main Methods:

  • Review of recent pharmacologic therapies.
  • Analysis of updated guidelines for IFI management.
  • Investigation into genetic factors influencing fungal infection risk.
  • Exploration of immunomodulation's role in IFIs.

Main Results:

  • New pharmacologic therapies are under investigation.
  • Guidelines for managing several IFIs have been revised.
  • Unique genetic factors are identified as risk modifiers for fungal infections.
  • The balance between immune integrity and graft protection is critical.

Conclusions:

  • Improving outcomes for transplant and oncology patients with IFIs requires continued progress.
  • Advances in understanding genetic predispositions and immunomodulation are crucial.
  • Addressing the evolving epidemiology and controversies in IFIs is essential for effective patient care.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...